# GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )

> **NCT02994836** · PHASE4 · COMPLETED · sponsor: **Fundación de Investigación Biomédica - Hospital Universitario de La Princesa** · enrollment: 139 (actual)

## Conditions studied

- Crohn's Disease
- Inflammatory Bowel Disease
- Ulcerative Colitis

## Interventions

- **BIOLOGICAL:** Anti-TNF: Infliximab (Infusion)
- **DRUG:** Anti-TNF discontinuation: Physiological saline solution
- **BIOLOGICAL:** Anti-TNF:Adalimumab (Subcutaneus)
- **DRUG:** Anti-TNF discontinuation: Physiological saline solution

## Key facts

- **NCT ID:** NCT02994836
- **Lead sponsor:** Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-21
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2023-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02994836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02994836, "GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02994836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*